Drug Chatter -- Tracking biopharma stock chatter

Profile for Cymabay Therapeutics Inc. (CBAY)

« Back to company index

CBAY Chatter Timeline

Stock Ticker for CBAY

Most Active Tweeters for CBAY

UserTweets
@Lblegend33 5
@TickerReport 3
@AmericanBanking 3
@stockboardinc 3
@GNWLive 3

Recent Tweets for CBAY

TribuneTrueBlue @TribuneTrueBlue
CymaBay Therapeutics Inc $CBAY Receives $14.50 Consensus PT from Analysts https://t.co/8WXvJCaJr7
January 14th 2018, 6:01pm
ZolmaxNews @ZolmaxNews
Oppenheimer Analysts Give CymaBay Therapeutics $CBAY a $15.00 Price Target https://t.co/vIihxfNux3
January 14th 2018, 8:01am
fireworkstrades @fireworkstrades
@pick1998_2 so u still own $CBAY? or planning to buy back. back to ATH this made nice money in 2017. thx for your picks and sharing..
January 13th 2018, 5:01pm
WeekHerald @WeekHerald
Somewhat Favorable Press Coverage Somewhat Unlikely to Impact CymaBay Therapeutics $CBAY Share Price https://t.co/GOn97Tm7z2
January 13th 2018, 7:01am
MaisaCorp @MaisaCorp
$CBAY announced the receipt of a $5 million milestone payment from Kowa Pharmaceuticals America for the initiation… https://t.co/7n55G3y3br
January 12th 2018, 5:01pm
Margare30926081 @Margare30926081
Dafna Capital Management Boosted Cymabay Therapeutics $CBAY Holding https://t.co/6lHhqBNLiu
January 12th 2018, 4:01pm
StockTexts @StockTexts
$CBAY CymaBay Therapeutics Inc. SEC Filing: Form 8-K https://t.co/pDQt0ZBSyN
January 12th 2018, 4:01pm
confcalltran @confcalltran
CymaBay is also filing this Form https://t.co/rGhRAkriyh $CBAY
January 12th 2018, 4:01pm
filingBot @filingBot
@swonger7 there is a new form 8-K filing for $CBAY https://t.co/xXlpztBJYg Fav if you like.
January 12th 2018, 4:01pm
noritsunagirota @noritsunagirota
Abingworth Llp Has Lowered Stake in Cymabay $CBAY by $458,224 as Share Value Rose https://t.co/Yf1dSEWC78
January 12th 2018, 3:01pm
ConsumerFeed @ConsumerFeed
Bank of New York Mellon Corp Increases Stake in CymaBay Therapeutics Inc $CBAY https://t.co/3MgF6DCl81
January 12th 2018, 4:01am
TheMarketsDaily @TheMarketsDaily
Oppenheimer Analysts Give CymaBay Therapeutics $CBAY a $15.00 Price Target https://t.co/jX38ydtqUy
January 11th 2018, 10:01pm
dispatchtribune @dispatchtribune
CymaBay Therapeutics $CBAY Given a $15.00 Price Target at Oppenheimer https://t.co/n1cEIzWNxV
January 11th 2018, 10:01pm
wosaikeneriki @wosaikeneriki
Dafna Capital Management Holds Stake in Cymabay Therapeutics $CBAY https://t.co/0cIfASk9Fv
January 11th 2018, 2:01pm
Jon12508683 @Jon12508683
like $cbay. multiple catalysts 1H2018.
January 11th 2018, 1:01pm
ConsumerFeed @ConsumerFeed
CymaBay Therapeutics Inc $CBAY Director Sells $43,903.00 in Stock https://t.co/Pdz0Afbm9l
January 11th 2018, 8:01am
dispatchtribune @dispatchtribune
Kurt Von Emster Sells 4,300 Shares of CymaBay Therapeutics Inc $CBAY Stock https://t.co/NQDyJ873TV
January 11th 2018, 8:01am
AmericanBanking @AmericanBanking
CymaBay Therapeutics Inc $CBAY Receives Consensus Recommendation of “Buy” from Brokerages https://t.co/yuAQP0iwQU #stocks
January 11th 2018, 2:01am
TranscriptDaily @TranscriptDaily
CymaBay Therapeutics Inc $CBAY Receives Consensus Recommendation of “Buy” from Analysts https://t.co/N09rQrrNKR
January 11th 2018, 2:01am
ARatings @ARatings
Oppenheimer Keeps Their Buy Rating on CymaBay Therapeutics $CBAY https://t.co/8AGwGyB2RN
January 10th 2018, 2:01pm
windham_kathryn @windham_kathryn
Cymabay Therapeutics, Inc. $CBAY Reaches $9.60 After 6.00% Up Move https://t.co/PKfFeQrIgK
January 10th 2018, 2:01pm
Lblegend33 @Lblegend33
$cbay conf tomorrow FYI
January 10th 2018, 1:01pm
bankerstribune @bankerstribune
Kurt Von Emster (Director) sold $44K worth of $CBAY. Cashflow models imply stock's overvalued https://t.co/XPzLRsj8pE
January 10th 2018, 12:01pm
MOMO_PIPE @MOMO_PIPE
A new daily high at $10 was just reached for $CBAY. Found with MOMO Realtime Stock Discovery & Alerts. #CBAY
January 10th 2018, 8:01am
WeekHerald @WeekHerald
Kurt Von Emster Sells 4,300 Shares of CymaBay Therapeutics Inc $CBAY Stock https://t.co/3J4Ip9ZbgD
January 9th 2018, 7:01pm
TickerReport @TickerReport
Insider Selling: CymaBay Therapeutics Inc $CBAY Director Sells 4,300 Shares of Stock https://t.co/lm9FaePivB
January 9th 2018, 7:01pm
AmericanBanking @AmericanBanking
Kurt Von Emster Sells 4,300 Shares of CymaBay Therapeutics Inc $CBAY Stock https://t.co/FOoz26klCz #stocks
January 9th 2018, 7:01pm
InsiderAlertsIA @InsiderAlertsIA
$CBAY: New Insider Filing on Director KURT VON EMSTER: https://t.co/4PnFAbOCek
January 9th 2018, 4:01pm
confcalltran @confcalltran
CymaBay Therapeutics director just disposed of 4,300 shares https://t.co/KA53JUMeZs $CBAY
January 9th 2018, 4:01pm
filingBot @filingBot
@swonger7 there is a new form 4 filing for $CBAY https://t.co/46qigDWudo What do you think?
January 9th 2018, 4:01pm
AlertTrade @AlertTrade
TREND REVERSAL DOWN ALERT: $CBAY CYMABAY THERAPEUTICS INC COMMON ? TradeIdeas via https://t.co/VS8RO1bzXJ to Free Trading Room
January 9th 2018, 11:01am
TribuneTrueBlue @TribuneTrueBlue
190,500 Shares in CymaBay Therapeutics Inc $CBAY Purchased by Ameriprise Financial Inc. https://t.co/B4VIxWS2fT
January 9th 2018, 8:01am
Gupta_Calling @Gupta_Calling
$CBAY anybody know when SELADELPAR Ph 2 PBC data is out? https://t.co/oP2EJuACkK
January 8th 2018, 3:01pm
NewsQuantified @NewsQuantified
$CBAY stocks falls -4.95% after reports received milestone payment from #KowaPharmaAmerica, #CymaBay https://t.co/aDbFDB5JYO
January 8th 2018, 1:01pm
PCGAdvisory @PCGAdvisory
$CBAY CymaBay Therapeutics Receives $5 Million Milestone Payment for Arhalofenate from Kowa Pharmaceuticals America https://t.co/nF90CFTNoR
January 8th 2018, 12:01pm
pbcadvocate @pbcadvocate
RT @StockNewsNow: $CBAY CymaBay Therapeutics Receives $5 Million Milestone Payment for Arhalofenate from Kowa Pharmaceuticals America https…
January 8th 2018, 11:01am
TriciaTNK @TriciaTNK
RT @odibro: $CBAY Receives $5 Million Milestone Payment for Arhalofenate from Kowa Pharmaceuticals
January 8th 2018, 11:01am
trade_to_profit @trade_to_profit
$CBAY Receives $5 Million Milestone Payment for Arhalofenate from Kowa Pharmaceuticals
January 8th 2018, 9:01am
StockNewsNow @StockNewsNow
$CBAY Enrollment Begins in Long-Term Extension Study of Seladelpar in Patients with Primary Biliary Cholangitis https://t.co/vSbCbbgVdp
January 8th 2018, 9:01am
StockNewsNow @StockNewsNow
$CBAY CymaBay Therapeutics Receives $5 Million Milestone Payment for Arhalofenate from Kowa Pharmaceuticals America https://t.co/IdnRvHUXld
January 8th 2018, 9:01am
stockboardinc @stockboardinc
$CBAY Enrollment Begins in Long-Term Extension Study of Seladelpar in Patients with Primary Biliary Cholan... - https://t.co/m5FfRtKe8z
January 8th 2018, 8:01am
stockboardinc @stockboardinc
$CBAY CymaBay Therapeutics Receives $5 Million Milestone Payment for Arhalofenate from Kowa Pharmaceutical... - https://t.co/6Mh9wecwmw
January 8th 2018, 8:01am
GNWLive @GNWLive
Enrollment Begins in Long-Term Extension Study of Seladelpar in Patients with Primary Biliary Cholangitis $CBAY https://t.co/GLjJ4CofUC
January 8th 2018, 8:01am
GNWLive @GNWLive
CymaBay Therapeutics Receives $5 Million Milestone Payment for Arhalofenate from Kowa Pharmaceuticals $CBAY https://t.co/ZfW8nqoD09
January 8th 2018, 8:01am
TickerReport @TickerReport
CymaBay Therapeutics $CBAY Receiving Somewhat Favorable Media Coverage, Report Finds https://t.co/u0zg8JFR7o
January 8th 2018, 4:01am
TickerReport @TickerReport
CymaBay Therapeutics $CBAY Receiving Somewhat Favorable Media Coverage, Report Finds https://t.co/y4ICBKtNzV
January 8th 2018, 4:01am
hkbbcatt @hkbbcatt
$CBAY this week close above $9.5 https://t.co/wTOj8svw6i
January 6th 2018, 2:01pm
noritsunagirota @noritsunagirota
Cymabay Therapeutics, Inc. $CBAY Reaches $9.69 52-Week High https://t.co/jUoBK38YY6
January 6th 2018, 10:01am
dailypoliticaln @dailypoliticaln
Brokerages Expect CymaBay Therapeutics Inc $CBAY to Announce -$0.12 Earnings Per Share https://t.co/NTQP7Cig9e
January 6th 2018, 10:01am
4thQuarterCap @4thQuarterCap
Trimmed $CBAY +57% thanks again @Pharmdca for showing me that one long time ago
January 5th 2018, 8:01pm

Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.